Nfocus Neuromedical Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $51M

Nfocus Neuromedical General Information

Description

Developer of medical devices intended to treat brain aneurysms. The company develops a single-deployment, easy-to-use embolization device that blocks blood flow while providing a scaffold to encourage tissue growth across an aneurysm opening and creating a plug, enabling patients to get treatment of intracranial aneurysms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2191 East Bayshore Road
  • Suite 100
  • Palo Alto, CA 94303
  • United States
+1 (650)
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Acquirer
Vertical(s)
TMT
Corporate Office
  • 2191 East Bayshore Road
  • Suite 100
  • Palo Alto, CA 94303
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nfocus Neuromedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 19-Feb-2013 $51M Completed Generating Revenue
5. Later Stage VC 12-Apr-2011 Completed Generating Revenue
4. Later Stage VC (Series C1) 01-Jul-2009 Completed Generating Revenue
3. Early Stage VC (Series B1) 26-Mar-2007 Completed Generating Revenue
2. Debt - General 29-Mar-2002 $500K $500K Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Nfocus Neuromedical’s complete valuation and funding history, request access »

Nfocus Neuromedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C1
Series B1
Series A1 13,897,591 $0.001000 $0.03 $0.09 $0.43 4x $0.09 9.11%
To view Nfocus Neuromedical’s complete cap table history, request access »

Nfocus Neuromedical Patents

Nfocus Neuromedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20030113478-A1 Plasma treating until a desired surface density of active species is formed; converting to a stable functional group; and optionally covalently attaching the modifying group to said group and reacting with a bioactive material Inactive 12-Dec-2001

Nfocus Neuromedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nfocus Neuromedical Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Draper Fisher Jurvetson Management Venture Capital Minority
Endeavour Vision Venture Capital Minority
GreenHills Ventures Venture Capital Minority
InCube Ventures Corporate Venture Capital Minority
Oxford Bioscience Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Nfocus Neuromedical Acquisitions (2)

Nfocus Neuromedical’s most recent deal was a Merger/Acquisition with StarFire Medical. The deal was made on 06-Mar-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
StarFire Medical 06-Mar-2008 Merger/Acquisition Therapeutic Devices
Acta Vascular Systems 03-Apr-2007 Merger/Acquisition Surgical Devices
To view Nfocus Neuromedical’s complete acquisitions history, request access »

Nfocus Neuromedical FAQs

  • When was Nfocus Neuromedical founded?

    Nfocus Neuromedical was founded in 1997.

  • Where is Nfocus Neuromedical headquartered?

    Nfocus Neuromedical is headquartered in Palo Alto, CA.

  • What is the size of Nfocus Neuromedical?

    Nfocus Neuromedical has 6 total employees.

  • What industry is Nfocus Neuromedical in?

    Nfocus Neuromedical’s primary industry is Surgical Devices.

  • Is Nfocus Neuromedical a private or public company?

    Nfocus Neuromedical is a Private company.

  • What is the current valuation of Nfocus Neuromedical?

    The current valuation of Nfocus Neuromedical is .

  • What is Nfocus Neuromedical’s current revenue?

    The current revenue for Nfocus Neuromedical is .

  • How much funding has Nfocus Neuromedical raised over time?

    Nfocus Neuromedical has raised $35.7M.

  • Who are Nfocus Neuromedical’s investors?

    Draper Fisher Jurvetson Management, Endeavour Vision, GreenHills Ventures, InCube Ventures, and Oxford Bioscience Partners are 5 of 7 investors who have invested in Nfocus Neuromedical.

  • When was Nfocus Neuromedical acquired?

    Nfocus Neuromedical was acquired on 19-Feb-2013.

  • Who acquired Nfocus Neuromedical?

    Nfocus Neuromedical was acquired by Covidien.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process